M3 muscarinic receptors mediate contraction of human urinary bladder

被引:125
|
作者
Fetscher, C
Fleichman, M
Schmidt, M
Krege, S
Michel, MC
机构
[1] Univ Essen Gesamthsch, Dept Med, D-4300 Essen, Germany
[2] Univ Essen Gesamthsch, Dept Pharmacol, D-4300 Essen, Germany
[3] Univ Essen Gesamthsch, Dept Urol, D-4300 Essen, Germany
关键词
E-max; maximum response; pEC(50); log of agonist concentration causing half-maximal effects;
D O I
10.1038/sj.bjp.0704781
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Since muscarinic receptors appear to be the physiologically most important control system for urinary bladder contraction, we have characterized the receptor subtype mediating contraction in response to the muscarinic agonist carbachol in the human bladder. Experiments were based on four antagonists, the non-selective atropine, the M-1-selective pirenzepine, the M-2-selective methoctramine and the M-3-selective darifenacin. All antagonists yielded Schild-plots with a slope close to unity. The order of potency (atropine greater than or equal to darifenacin > pirenzepine > methoctramine) as well as the estimated antagonist affinities suggested that contraction of the human bladder occurs predominantly if not exclusively via the M-3 receptor.
引用
收藏
页码:641 / 643
页数:3
相关论文
共 50 条
  • [41] Targeting M3 Muscarinic Receptors for Colon Cancer Therapy
    Felton, Jessica
    Hu, Shien
    Raufman, Jean-Pierre
    CURRENT MOLECULAR PHARMACOLOGY, 2018, 11 (03) : 184 - 190
  • [42] Inhibition of m3 muscarinic acetylcholine receptors by local anaesthetics
    Hollmann, MW
    Ritter, CH
    Henle, P
    de Klaver, M
    Kamatchi, GL
    Durieux, ME
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (01) : 207 - 216
  • [43] Aging and hypertrophy change the muscarinic receptor subtype mediating bladder contraction from M3 towards M2
    Braverman, AS
    Karlovsky, M
    Pontari, MA
    Ruggieri, MR
    JOURNAL OF UROLOGY, 2002, 167 (04): : 43 - 43
  • [44] Role of the M2 muscarinic receptor in contraction of mouse urinary bladder
    Pak, Kirk J.
    Park, Grace J.
    Ahn, Simon
    Sangnil, Marline S.
    Matsui, Minoru
    Ostrom, Rennolds S.
    Ehlert, Frederick J.
    FASEB JOURNAL, 2007, 21 (06): : A1162 - A1162
  • [45] M2 AND M3 MUSCARINIC RECEPTOR EXPRESSION IN BLADDER TUMOR
    Asutay, Mehmet Kazim
    Aydin, Banu
    Toper, Hasan
    Filinte, Deniz
    Cabadak, Hulya
    Tinay, Ilker
    JOURNAL OF UROLOGY, 2018, 199 (04): : E778 - E778
  • [46] Differential agonist-induced regulation of human M2 and M3 muscarinic receptors
    Stope, MB
    Kunkel, C
    Kories, C
    Schmidt, M
    Michel, MC
    BIOCHEMICAL PHARMACOLOGY, 2003, 66 (11) : 2099 - 2105
  • [47] M1 AND M3 MUSCARINIC RECEPTORS MEDIATE 2 TYPES OF MEMBRANE ELECTRICAL RESPONSES IN XENOPUS-OOCYTES
    ORON, Y
    LUPUMEIRI, M
    SHAPIRA, H
    DAVIDSON, A
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, : 101 - 101
  • [48] ON THE MUSCARINIC RECEPTORS IN THE URINARY-BLADDER AND THE PUTATIVE SUBCLASSIFICATION OF MUSCARINIC RECEPTORS
    NILVEBRANT, L
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 1 - +
  • [49] Expression of muscarinic acetylcholine receptors M3 and M5 in osteoporosis
    Kauschke, Vivien
    Lips, Katrin Susanne
    Heiss, Christian
    Schnettler, Reinhard
    MEDICAL SCIENCE MONITOR, 2014, 20 : 869 - 874
  • [50] M3-type muscarinic receptors predominantly mediate neurogenic quick contraction of bovine ciliary muscle
    Masuda, H
    Goto, M
    Tamaoki, S
    Kamikawatoko, S
    Tokoro, T
    Azuma, H
    GENERAL PHARMACOLOGY, 1998, 30 (04): : 579 - 584